# Physalin F, a Potent Inhibitor of Lymphocyte Function, Is a Calcineurin Inhibitor and Has Synergistic Effect with Dexamethasone

**Authors:** Dahara Keyse Carvalho Silva, Laura Beatriz da Cruz Novo, Ivone Maria Ribeiro, Breno Cardim Barreto, Luiza Carolina França Opretzka, Cássio Santana Meira, Milena Botelho Pereira Soares

PMC · DOI: 10.3390/molecules30040916 · Molecules · 2025-02-16

## TL;DR

Physalin F, a natural compound, suppresses immune responses and works better with dexamethasone, showing promise as a treatment for immune-related diseases.

## Contribution

Physalin F is identified as a calcineurin inhibitor with synergistic effects when combined with dexamethasone, offering a novel immunosuppressive strategy.

## Key findings

- Physalin F inhibits lymphocyte proliferation and reduces cytokine production in activated splenocytes.
- Combining physalin F with dexamethasone shows synergistic immunosuppressive effects in vitro.
- Physalin F reduces calcineurin activity and paw edema in a delayed-type hypersensitivity model in vivo.

## Abstract

The dysregulation of immune responses are responsible for the development of several diseases, such as allergic and autoimmune diseases. The medications used to treat these conditions have numerous side effects, creating the need for new drugs. Physalins are natural compounds with various pharmacological activities already described. Here, we aimed to investigate the immunomodulatory effects of physalin F in mouse splenocytes and in a delayed-type hypersensitivity (DTH) model. In a cytotoxicity assay, physalin F had low cytotoxicity to mouse splenocytes in concentrations equal to or below 2 µM. It significantly inhibited lymphocyte proliferation in a concentration-dependent manner and reduced the production of cytokines, including IL-2, IL-4, IL-10, and IFN-γ, in activated splenocytes. The combined therapy of physalin F with dexamethasone was investigated in vitro, showing a synergistic action of the two compounds. Mechanistically, physalin F reduced calcineurin activity in concanavalin A-stimulated splenocyte cultures. Finally, in vivo, the intraperitoneal administration of physalin F in a DTH model reduced paw edema induced by bovine serum albumin immunization. Our results demonstrate the potential of physalin F as an immunosuppressive agent, to be used alone or in combination with glucocorticoids.

## Linked entities

- **Proteins:** ppp3ca.S (protein phosphatase 3, catalytic subunit, alpha isozyme S homeolog)
- **Chemicals:** physalin F (PubChem CID 49864133), dexamethasone (PubChem CID 5743), IL-2 (PubChem CID 51397006), IL-4 (PubChem CID 171905173), IL-10 (PubChem CID 146070)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}
- **Diseases:** edema (MESH:D004487), cytotoxicity (MESH:D064420), DTH (MESH:D006968), allergic and autoimmune diseases (MESH:D001327)
- **Chemicals:** Physalins (-), Physalin F (MESH:C075425), Dexamethasone (MESH:D003907)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11858416/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11858416/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC11858416/full.md

---
Source: https://tomesphere.com/paper/PMC11858416